Why Should You Attend:The European Commission has passed and published the final version of Annex 13 ("Investigational Medicinal Products") to the EC GMP Guide. The new Annex comes into force in July 2010. It calls for special attention in areas to GMP conformity for investigational medicinal product by personnel working on clinical trials. Compliance can be achieved especially thorough training, some possible changes in processes and revision of some GMP standard operating procedures. These enhanced requirements reflected in the revision of Annex 13 are part of the strict regulations now in force in the European Community.